| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $468.3M | — | +11.5% |
| Cost of Revenue | $281.7M | — | +29.8% |
| Gross Profit | $186.6M | — | -8.0% |
| R&D Expense | $23.2M | — | +13.2% |
| SG&A Expense | $210.6M | — | +42.8% |
| Operating Income | -$67.0M | — | -546.7% |
| Pre-tax Income | -$108.7M | — | -352.9% |
| Income Tax | $4.8M | — | +23.1% |
| Net Income | -$113.5M | — | -309.7% |
| EPS (Basic) | -$2.87 | — | -103.5% |
| EPS (Diluted) | -$2.87 | — | -103.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $824.9M | +1.5% | +95.4% |
| Accounts Receivable | $353.1M | +18.1% | -12.3% |
| Inventory | $487.3M | -12.0% | -23.1% |
| Current Assets | $1.92B | -0.1% | +17.4% |
| Total Assets | $5.47B | -2.7% | +65.4% |
| Current Liabilities | $638.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Capital Expenditures | $10.4M | — | -57.2% |
| +39.5% |
| Long-term Debt | $2.53B | -0.3% | +178.9% |
| Total Liabilities | $3.52B | -1.3% | +109.4% |
| Stockholders' Equity | $1.96B | -5.2% | +20.1% |